内科学(循環器)

Medicine & Life Sciences

1. Transcatheter Aortic Valve Replacement 100%
2. Cardiac Myocytes 87%
3. Heart Failure 84%
4. Registries 78%
5. Percutaneous Coronary Intervention 72%
6. Atrial Fibrillation 53%
7. Japan 45%
8. Heart 45%
9. Induced Pluripotent Stem Cells 44%
10. Pulmonary Hypertension 41%
11. Pulmonary Arterial Hypertension 31%
12. Catheter Ablation 29%
13. Myocardial Infarction 28%
14. Mortality 28%
15. Pluripotent Stem Cells 24%
16. Cardiovascular Diseases 24%
17. Balloon Angioplasty 24%
18. Therapeutics 23%
19. Acute Coronary Syndrome 22%
20. Lung 19%
21. Confidence Intervals 19%
22. Brain Natriuretic Peptide 18%
23. Hydrogen 17%
24. Hemorrhage 17%
25. Embryonic Stem Cells 16%
26. Aortic Valve Stenosis 16%
27. Pressure 16%
28. Cardiac Arrhythmias 16%
29. Incidence 15%
30. Odds Ratio 15%
31. Hemodynamics 14%
32. Electrocardiography 14%
33. Stem Cells 14%
34. Hospitalization 14%
35. Coronary Artery Disease 14%
36. Catheters 14%
37. Regenerative Medicine 13%
38. Aortic Valve 13%
39. Atrial Appendage 13%
40. Heart Diseases 13%
41. Echocardiography 13%
42. Genes 12%
43. Gases 12%
44. Kidney 12%
45. Multidetector Computed Tomography 12%
46. Coronary Vessels 12%
47. Brugada Syndrome 12%
48. Ventricular Fibrillation 11%
49. Paroxysmal ventricular fibrillation 11%
50. Stroke 11%
51. Hospital Mortality 11%
52. Safety 11%
53. Leukemia Inhibitory Factor 11%
54. Stroke Volume 11%
55. Mutation 11%
56. Sudden Cardiac Death 11%
57. Databases 11%
58. Swine 10%
59. Ventricular Remodeling 10%
60. Inhalation 10%
61. Coronavirus 10%
62. Heart Atria 10%
63. Photosensitivity Disorders 10%
64. Familial Primary Pulmonary Hypertension 10%
65. Cardiomegaly 10%
66. Epoprostenol 9%
67. Acute Kidney Injury 9%
68. Heart Valves 9%
69. Pulmonary Artery 9%
70. Endothelin-1 9%
71. Myocardium 9%
72. Superior Vena Cava 9%
73. Mesenchymal Stem Cells 9%
74. Cardiomyopathies 9%
75. Aortic Valve Insufficiency 9%
76. Elderly 8%
77. Regeneration 8%
78. Cohort Studies 8%
79. Inflammation 8%
80. Angiotensin II 8%
81. Ischemia 8%
82. Nerve Growth Factor 8%
83. Fibroblasts 8%
84. Frailty 8%
85. Phenotype 8%
86. Tachycardia 8%
87. Chronic Renal Insufficiency 8%
88. Population 8%
89. Atrial Heart Septal Defects 8%
90. Reperfusion 8%
91. Infarction 8%
92. Canidae 8%
93. Heart Ventricles 8%
94. Atrial Remodeling 8%
95. C-Reactive Protein 8%
96. Thrombosis 8%
97. Deep Learning 8%
98. Talaporfin 8%
99. Pulmonary Veins 8%
100. Granulocyte Colony-Stimulating Factor 8%